DCM
ANIP icon

Dupont Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Dupont Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-18,251
Closed -$1.18M – 952
2017
Q4 		$1.18M Buy
18,251
+9,684
+113% +$602K 0.03% 485
2017
Q3 		$450K Buy
+8,567
New +$409K 0.01% 697
2016
Q3 		– Sell
-7,955
Closed -$444K – 655
2016
Q2 		$444K Sell
7,955
-5,938
-43% -$289K 0.01% 595
2016
Q1 		$468K Hold
13,893
– – 0.01% 552
2015
Q4 		$627K Sell
13,893
-362
-3% -$15.6K 0.02% 550
2015
Q3 		$563K Buy
14,255
+4,925
+53% +$280K 0.01% 522
2015
Q2 		$579K Hold
9,330
– – 0.01% 499
2015
Q1 		$584K Hold
9,330
– – 0.01% 495
2014
Q4 		$526K Buy
+9,330
New +$411K 0.01% 542

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return